A detailed history of Ensign Peak Advisors, Inc transactions in Insmed Inc stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 484,121 shares of INSM stock, worth $34.1 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
484,121
Previous 359,029 34.84%
Holding current value
$34.1 Million
Previous $24.1 Million 46.92%
% of portfolio
0.06%
Previous 0.04%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$62.0 - $79.01 $7.76 Million - $9.88 Million
125,092 Added 34.84%
484,121 $35.3 Million
Q2 2024

Aug 13, 2024

BUY
$22.0 - $69.71 $384,010 - $1.22 Million
17,455 Added 5.11%
359,029 $24.1 Million
Q1 2024

May 14, 2024

BUY
$25.72 - $29.94 $6.98 Million - $8.13 Million
271,564 Added 387.89%
341,574 $9.27 Million
Q4 2023

Feb 14, 2024

BUY
$23.42 - $31.74 $101,642 - $137,751
4,340 Added 6.61%
70,010 $2.17 Million
Q1 2023

May 15, 2023

SELL
$16.26 - $21.73 $3.8 Million - $5.08 Million
-233,553 Reduced 78.05%
65,670 $1.12 Million
Q4 2022

Feb 13, 2023

BUY
$16.98 - $23.15 $1.5 Million - $2.04 Million
88,100 Added 41.73%
299,223 $5.98 Million
Q3 2022

Nov 14, 2022

BUY
$20.88 - $28.21 $1.03 Million - $1.39 Million
49,426 Added 30.57%
211,123 $4.55 Million
Q2 2022

Aug 12, 2022

BUY
$17.07 - $25.71 $2 Million - $3.01 Million
116,937 Added 261.25%
161,697 $3.19 Million
Q1 2022

May 16, 2022

BUY
$20.42 - $28.13 $338,972 - $466,958
16,600 Added 58.95%
44,760 $1.05 Million
Q4 2021

Feb 11, 2022

BUY
$25.89 - $33.45 $729,062 - $941,952
28,160 New
28,160 $767,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.56B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.